Latest Market Research Reports

  U.S. Continuous Renal Replacement Therapy Industry The   U.S. continuous renal replacement therapy (CRRT) market   size is expected to reach USD 957.2 million by 2028, according to a new report by Grand View Research, Inc. The market is projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028. The anticipated growth in the U.S. market can be attributed to the rising number of ICU patients suffering from Acute Kidney Injury (AKI) and the increasing incidence of sepsis. Additionally, the COVID-19 pandemic has positively impacted the market, further driving its growth. The presence of well-established key players in the country, who are focused on developing and commercializing technologically advanced devices, along with government initiatives to raise awareness about CRRT, are also expected to support market expansion during the forecast period. The growing prevalence of fluid overload, a condition that often affects AKI patients in critical ...

U.S. Continuous Renal Replacement Therapy Industry Overview The U.S. continuous renal replacement therapy market size was valued at USD 601.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028.  The growth of the U.S. market can be attributed to the rising incidence of Acute Kidney Injury (AKI) and sepsis, rapid increase in the number of hospitals and urgent care centers, rising hospital admission rate, and constant product launches by prominent market players. In addition, the COVID-19 outbreak has resulted in significant demand for continuous renal replacement therapy (CRRT) in the U.S. Owing to this, the market has witnessed regulatory support from various government authorities and a rise in financial incentives. These factors are expected to contribute to the growth of the U.S. market during the forecast period. Gather more insights about the market drivers, restrains and growth of the U.S. Continuous Renal Replaceme...